Our case report may represent a treatment option for patients withtreatment-resistant schizophrenia, who display partial responses to clozapine and face the risk of developing a metabolic syndrome. This effective, though extreme, polypharmacy of treatment-resistant schizophrenia require further evidence and confirmative data and should be used only in severe, selected cases, with the full consent and compliance of patients.
Is a high dosage aripiprazole-clozapine combination an effective strategy for treatment-resistant schizophrenic patients? A case report
TOFFANIN, TOMMASO
Secondo
Conceptualization
;
2009
Abstract
Our case report may represent a treatment option for patients withtreatment-resistant schizophrenia, who display partial responses to clozapine and face the risk of developing a metabolic syndrome. This effective, though extreme, polypharmacy of treatment-resistant schizophrenia require further evidence and confirmative data and should be used only in severe, selected cases, with the full consent and compliance of patients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
